Literature DB >> 8140953

Molecular genetic studies of the adenoma-carcinoma sequence.

E R Fearon1.   

Abstract

During the past decade, a great deal of progress has been made toward identifying some of the genetic alterations that underlie human cancer development in general, and colorectal cancer in particular. It is now clear that mutations in both oncogenes and tumor suppressor genes have an important role in the process. However, much work lies ahead before a complete understanding of the pathogenesis of colorectal tumors will be obtained. It seems reasonable to predict that additional oncogenes and tumor suppressor genes with important roles in colorectal cancer remain to be identified. Characterization of the function of these genes in normal and neoplastic cell growth will be crucial. Unfortunately, we know little about the functions of the oncogenes and tumor suppressor genes already implicated in colorectal cancer. Undoubtedly, it will be crucial to understand the role of environmental and dietary influences on the nature and rate of mutations in colorectal tumors. Little is known about the relative significance of each of the various inherited and somatic mutations to the cancer phenotype. Moreover, although some preliminary studies have suggested possible clinical applications of the genetic studies to improved diagnosis and management of patients at risk of and harboring colorectal cancer, the scope and significance of the observations thus far are limited. Nevertheless, an optimistic view is that future molecular genetic studies not only will yield insights into the molecular basis of colorectal cancer, but also will improve the care of patients with colorectal tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8140953

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN: 0065-2822


  21 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.

Authors:  N Arber; S Kuwada; M Leshno; R Sjodahl; R Hultcrantz; D Rex
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

3.  Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Hang Yang; Jianbo Zhao; Aping Yuan; Jon Florholmen
Journal:  Pathol Oncol Res       Date:  2014-05-25       Impact factor: 3.201

4.  Molecular damage in the bronchial epithelium of current and former smokers.

Authors:  I I Wistuba; S Lam; C Behrens; A K Virmani; K M Fong; J LeRiche; J M Samet; S Srivastava; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1997-09-17       Impact factor: 13.506

5.  Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.

Authors:  Robert P Whitehead; Sheryl McCoy; John S Macdonald; Saul E Rivkin; Marcus A Neubauer; Shaker R Dakhil; Heinz-Josef Lenz; Michael S Tanaka; James L Abbruzzese
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

6.  Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide.

Authors:  M Röpke; J Hald; P Guldberg; J Zeuthen; L Nørgaard; L Fugger; A Svejgaard; S Van der Burg; H W Nijman; C J Melief; M H Claesson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases.

Authors:  J C Weber; A Schneider; S Rohr; H Nakano; P Bachellier; A Méchine; G Hamel; M Kanor; M P Chenard; M P Gaub; P Oudet; C Meyer; D Jaeck
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

8.  Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?

Authors:  Photini F S Rice; Kevin G Ehrichs; Mykella S Jones; Hwudarw Chen; Chiu-Hsieh Hsu; Edward R Abril; Raymond B Nagle; David G Besselsen; Jennifer K Barton; Natalia A Ignatenko
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-08

9.  KRAS mutations and subtyping in colorectal cancer in Jordanian patients.

Authors:  Wafa M Elbjeirami; Maher A Sughayer
Journal:  Oncol Lett       Date:  2012-07-04       Impact factor: 2.967

10.  Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.

Authors:  A Syed Sameer; Shakeel ul Rehman; Arshad A Pandith; Nidda Syeed; Zaffar A Shah; Nissar A Chowdhri; Khursheed A Wani; Mushtaq A Siddiqi
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.